Comparing the current results to its competitors, Profound Medical reported Revenue increase in the 1 quarter 2026 by 103.62 % year on year. The sales growth was above Profound Medical 's competitors' average revenue growth of 4.52 %, achieved in the same quarter.
Profound Medical Corp , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 12.43 %
November 26, 2024
In an era where innovation is paramount, Profound Medical continues to assert its presence in the medical technology sector with significant advancements and a focus on clinical efficacy. The company is gearing up to unveil its next TULSA-AI module, the UA Alignment Assistant, at the upcoming Radiological Society of North America (RSNA) and Society of Urologic Oncology (SUO) meetings. This latest development underscores Profound Medical’s commitment to revolutionizing TULSA (Transurethral Ultrasound Ablation) procedures, which are lauded for their unrivaled flexibility and real-world efficacy.The TULSA procedures, a hallmark of Profound Medical’s offerings, provide urologists with enhanced capabilities t...
May 6, 2024
Prostate diseases, including prostate cancer and benign prostatic hyperplasia (BPH), pose significant health challenges for men worldwide. The traditional treatment options for these conditions often involve surgery or radiation, which can lead to undesirable side effects and complications. However, recent advancements in the TULSA (Transurethral Ultrasound Ablation) procedure are rapidly positioning it as a potential mainstream treatment modality, offering patients a safer and more effective alternative. This article delves into the growing body of clinical evidence surrounding the TULSA procedure and highlights its potential to revolutionize prostate disease management.Clinical Evidence Supporting the Use ...
Atricure Inc is a medical device company that focuses on developing, manufacturing, and selling innovative surgical solutions for the treatment of cardiac arrhythmias and other heart-related conditions.
Guided Therapeutics Inc operates on a business model focused on developing and commercializing medical devices for the early detection and monitoring of diseases, with a particular emphasis on cervical cancer.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
Hyperfine Inc operates on a business model that focuses on designing and manufacturing portable and affordable magnetic resonance imaging (MRI) systems, enabling medical professionals to access advanced imaging technology at a lower cost, expanding the reach of MRI diagnostics.
Icad Inc operates on a business model that focuses on the development and commercialization of innovative cancer detection and therapy solutions. They primarily generate revenue through the sale of their advanced medical devices and software solutions to hospitals, clinics, and research institutions worldwide. Their business strategy revolves around continuous innovation, strategic partnerships, and a commitment to providing effective tools for early detection and treatment of cancer.
Sources:
Profound Medical Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Profound Medical Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
